|
HU1900172A2
|
|
Topical composition comprising apremilast
|
|
WO2019102240A1
|
|
Method for the manufacture of lumateperone and its salts
|
|
HU1800397A2
|
|
Process for the preparation of lumateperone and salts thereof
|
|
WO2018215807A1
|
|
Process for the production of ozanimod
|
|
HU231112B1
|
|
Method for the preparation of ozanimod
|
|
HU1700288A1
|
|
Variable dose metering device and a dispensing device with such dose metering device, and a locking device group for the dispensing device
|
|
HU1700236A2
|
|
New polymorph and solvate of idelalisib
|
|
HU1600613A2
|
|
Crystalline forms of sacubitril hemicalcium salt
|
|
HU1600436A2
|
|
Salts for the preparation of a pharmaceutical composition
|
|
HU1600415A2
|
|
Pimavanserin salts for the manufacture of pharmaceutical formulations
|
|
HU1600087A2
|
|
Method for producing morphologically homogenous mirabegron and mirabegron monohydrochloride
|
|
HU1600058A2
|
|
Process for the preparation of pomalidomide
|
|
HU1600051A2
|
|
Mirabegron cocrystals
|
|
HU1600030A2
|
|
Baricitinib salts
|
|
HU1500647A2
|
|
Intermediate of baricitinib and process for its preparation
|
|
HU1500577A2
|
|
New polymorph and solvate of idelalisib
|
|
HU1500506A2
|
|
Salts of palbociclib
|
|
HU1500469A2
|
|
Use of a combination of deramciclane and non-steroidal anti-inflammatory drugs to achieve improved anti-inflammatory effect
|
|
HU1500034A2
|
|
Process for the preparation of vortioxetine salts
|
|
CN106103418A
|
|
The fertile preparation method for western spit of fland salt
|
